APS
29th APS Annual Convention · 2017
CSF Biomarker and Neuropsychological Predictors of Cognitive Progression in Parkinson's Disease
- Brenda Hanna-Pladdy
University of Maryland School of Medicine - Spenser Haffey
University of Maryland School of Medicine
Abstract
To evaluate baseline biomarker predictors of cognitive progression in Parkinson’s disease (PD), we evaluated a sample of 126 de novo patients from the PPMI database. Patients were assessed at baseline regarding CSF proteins (Aβ1-42, t-tau, p-tau181, α-synuclein), APOE, REM sleep, UPDRS and at baseline and 4 year follow-up on cognition.
Neuropsychology
